Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT07390448

Recruiting

Rhomboid Intercostal Sub-serratus Plane Blocks and Erector Spinae Plane Block in Mastectomy Surgeries

Breast Cancer
NCT07376538

Recruiting

Response-Based Local Therapy for Regionally Advanced Breast Cancer

Breast Cancer
NCT07371208

Recruiting

Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer (ST-A-TN)

Breast Cancer
NCT07370571

Not yet recruiting

NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE) (OXIGENATE)

Breast Cancer
NCT07368998

Recruiting

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer (optINAVO)

Breast Cancer
NCT07353437

Not yet recruiting

Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)

Breast Cancer
NCT07350928

Recruiting

Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status

Breast Cancer
NCT07320521

Not yet recruiting

A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

Breast Cancer
NCT07304934

Not yet recruiting

A Single-arm, Prospective, Multi-center Cohort Study Based on Deep Learning-based cfDNA Fragment Omics to Verify the TuFEst Model for the Staging Diagnosis of Breast Cancer Lesions and Lymph Nodes

Breast Cancer
NCT07305246

Not yet recruiting

Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer

Breast Cancer
NCT07299890

Not yet recruiting

An Exploratory Study of Pertuzumab and Trastuzumab in Combination With Palbociclib and Exemestane as Neoadjuvant Therapy for Triple-Positive Breast Cancer

Breast Cancer
NCT07294703

Recruiting

Factors Associated With Breast Cancer Risks and Outcomes

Breast Cancer
NCT07267572

Not yet recruiting

Evaluation of the Added Value of Logotherapy in the Psychological Support of Patients With Primary Breast Cancer (AELO)

Breast Cancer
NCT07245797

Not yet recruiting

A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC

Breast Cancer
NCT07243002

Recruiting

Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters. (REPOWER)

Breast Cancer
NCT07227233

Recruiting

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. (AIM-BRIGHT)

Breast Cancer
NCT07218250

Recruiting

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer

Breast Cancer
NCT07207070

Recruiting

A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.

Breast Cancer
NCT07197697

Not yet recruiting

A Phase II Exploratory Study of Iparomlimab and Tuvonralimab Combined With Chemotherapy in Neoadjuvant Treatment of HR+/HER2- Breast Cancer Patients

Breast Cancer
NCT07169539

Not yet recruiting

Digital Tool for Psychological Support in Women With Breast Cancer (SerenApp)

Breast Cancer
NCT07164976

Recruiting

Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer

Breast Cancer
NCT07619781

Active, not recruiting

Research on the Development and Validation of Personalized Exercise Prescriptions for Breast Cancer Patients Based on Large Language Models

Breast Cancer
NCT07587983

Completed

Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer

Breast Cancer
NCT07298980

Enrolling by invitation

ExBRAC- Expressive Writing in Breast Cancer (ExBRAC)

Breast Cancer
NCT07581054

Completed

Super-Resolution Ultrasound Microvascular Mapping for Non-Invasive Breast Cancer Molecular Subtyping: A Validated Nomogram (SRUS-Map)

Breast Cancer
NCT07140965

Suspended

The Impact of Surgeon-Interpreted Intraoperative Margin Assessment During Breast Conserving Surgery on Postoperative Treatment

Breast Cancer
NCT07512063

Completed

A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors

Breast Cancer
NCT07510997

Completed

Perioperative Individually Tailored Psychological Intervention in Breast Cancer Surgery

Breast Cancer
NCT07487129

Completed

Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt (Clinical and P)

Breast Cancer
NCT07328321

Completed

Development and Assessment of the 8-item Chronic Pain Acceptance Questionnaire to Measure Disease Acceptance in Women With Breast Cancer (CPAQ-8-BC)

Breast Cancer
NCT07080463

Enrolling by invitation

Application of VascuLens 2.0, A Mixed Reality System for Surgical Guidance During DIEP Flap Harvest (VascuLens RCT)

Breast Cancer
NCT07426653

Completed

Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.

Breast Cancer
NCT07320781

Completed

Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

Breast Cancer
NCT07317765

Active, not recruiting

Research on New Methods and New Models of Rehabilitation Intervention for Cancer Patients Based on Exercise and Psychological Intervention

Breast Cancer
NCT07311278

Active, not recruiting

Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients (INFLUENCE II)

Breast Cancer
NCT07262099

Completed

Study of Effects of Dao-yin Exercise on the Patients With Breast Cancer Post Operation and Receiving Adjuvant Chemotherapy

Breast Cancer
NCT07199556

Completed

Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors. (DOLFLEX)

Breast Cancer
NCT04131972

Completed

REGENERA Implant in Excised Non-Malignant Breast Lesions

Benign Breast Disease
NCT03323658

Completed

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Invasive Breast Carcinoma
NCT02848989

Completed

Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors

Breast Cancer | Breast Cancer Surgery Pain | Stage 0-III Breast Cancer
NCT03401034

Completed

Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer Prognosis

Inflammation | Breast Cancer | Lifestyle | Hormone Therapy | Breast Cancer Mortality | Inflammatory Biomarkers | Breast Cancer Survival | Postmenopausal Breast Cancer | Genetic Factors | Phytoestrogens
NCT06827613

Recruiting

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors (START-002)

HR+, HER2-, Advanced Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast Cancer
NCT06348134

Recruiting

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Breast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
NCT05910710

Recruiting

Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Triple Negative Breast Cancer | Pembrolizumab | Neoadjuvant Chemotherapy | Tumor Microenvironment
NCT06038539

Terminated

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
NCT06585969

Withdrawn

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer (DISCORDANT)

Metastatic Breast Cancer | ER-positive Breast Cancer | Luminal B | Her2 Enriched | Basal Like
NCT02521363

Completed

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Breast Cancer
NCT07013422

Completed

The Effectiveness of Psychoeducational Intervention in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed With Breast Cancer

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT03737500

Completed

Standard Silicone-based vs. B-Lite® Light Weight Breast Implant After Total Mastectomy and Radiotherapy for Breast Cancer (BLITE-01)

Breast Cancer | Radiotherapy Side Effect | Breast Implant; Complications | Breast Implant Protrusion
NCT03969121

Completed

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations